Skip to content

Prospective observational study of lymphoma in children, adolescents and young adults

Prospective observational study of lymphoma in children, adolescents and young adults - PL-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043309
Enrollment
1300
Registered
2021-02-15
Start date
2021-03-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma

Interventions

None listed

Sponsors

Japan Children's Cancer Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: lymphoma using WHO calcification (exclude leukemia) Under 30 year-old at initial diagnosis Patients who agree with registration of JPLSG CHM-14 Patients who agree with registration of JPLSG PL-19 (this study)

Exclusion criteria

Exclusion criteria: Lymphoblastic leukemia

Design outcomes

Primary

MeasureTime frame
Overall survival period of each lymphoma

Secondary

MeasureTime frame
Event free survival period of each lymphoma relapse and progression time of each lymphoma occurrence rate of second malignancy in each lymphoma Overall survival period according each treatment method Event free survival period according each treatment method Relapse time according each treatment method

Countries

Japan

Contacts

Public ContactDaiki Hori

Sapporo Hokuyu hospital Department of Hematology/Oncology for Children and Adolescents

pippen33_dh@yahoo.co.jp011-865-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026